Srp-9001-301
ClinicalTrials.gov NCT05096221
Research payments
$2,939,407
Through program year 2025, $2,939,407 in research payments was reported against Srp-9001-301, across 1,638 payments, paid by Sarepta Therapeutics, Inc..
- Paid by
- Sarepta Therapeutics, Inc.
- ClinicalTrials.gov
- NCT05096221
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $662,570 | 331 |
| 2024 | Research | $2,123,070 | 1,052 |
| 2023 | Research | $10,532 | 48 |
| 2021 | Research | $143,235 | 207 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Carmen Leon Astudillo Gainesville, FL Named on 115 payments
- Anne Connolly Columbus, OH Named on 100 payments
- Emma Ciafaloni Rochester, NY Named on 96 payments
- Nancy Bass Milwaukee, WI Named on 91 payments
- Craig Zaidman Saint Louis, MO Named on 82 payments
- Aravindhan Veerapandiyan Little Rock, AR Named on 80 payments
- Russell Butterfield Salt Lake City, UT Named on 69 payments
- Michio Hirano New York, NY Named on 67 payments
- Mai El Mallah Durham, NC Named on 58 payments
- Partha Ghosh Rochester, MN Named on 54 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.